← Human Trials & Peer-Reviewed Studies
Dopamine infusion enhances the adrenocorticotropic hormone and cortisol response to metoclopramide in hyperprolactinemic patients but not in normal subjects
Plain-language guide to PMID 9209895 (1997): randomized controlled trial study of ACTH (Corticotropin), hyperparathyroidism.
Key Facts
- PMID
- 9209895
- Journal
- Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
- Year
- 1997
- Study type
- Randomized Controlled Trial
- Authors
- Moro M et al. (3 authors)
- DOI
- 10.3109/09513599709152529
What This Study Did, in Plain Language
What Was Tested
Researchers studied ACTH (Corticotropin) in the context of hyperparathyroidism in this randomized controlled trial publication.
Who Took Part
The age groups tagged for this paper are adults and middle-aged adults, both men and women.
How the Study Was Run
In design terms this was a randomized study.
Random assignment meant chance, not the researchers, decided who got ACTH (Corticotropin) and who got the comparison, which limits bias.
What Was Measured
The subject headings attached to it are Adrenocorticotropic Hormone, Dopamine, Dopamine Antagonists, Hydrocortisone, Hyperprolactinemia, Infusion Pumps and Metoclopramide.
What This Means in Plain Language
The paper is a randomized study of ACTH (Corticotropin) in people with hyperparathyroidism.
The publication is from 1997 (Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology), a journal based in England.
More context: the ACTH (Corticotropin) compound page, Hyperparathyroidism research.
Our Notes on the Compound
ACTH (Corticotropin): The 39-amino-acid pituitary hormone that drives cortisol production; given as repository corticotropin (Acthar Gel).
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.